Non-small cell lung cancer stage III

• Phase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer. Pending
  2024-514001-65-00 3 "Non-Small Cell Lung Cancer"
• A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacitu … Pending
  2024-517561-16-00 4 "non-small cell lung cancer"
• Phase II, open label, single arm, multicenter study to assess the activity and safety of ALectinib as NE O adjuvant therapy in patients with … Pending
  2024-519106-12-00 4 "Patients with anaplastic lymphoma kinase positive (ALK+) loc"
• Phase II, clinical trial, to evaluate OS in two cohorts in relapsed stage III non-small-cell lung cancer (NSCLC) pretreated with chemoradiot … Pending
  2024-520081-65-00 4 "NSCLC non-small cell lung cancer"
• Phase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer Pending
  2025-520946-31-00 1 "Non-Small Cell Lung Cancer"
• A clinical study to assess the efficacy of adjuvant immunotherapy with cemiplimab in patients with surgically removed non-small cell lung ca … Recruiting
  2024-519901-36-00 5 2025-12-17 "Patients with resected stage II-IIIA non-small cell lung can"
• A Multicenter, Open-Label, Dose-Finding, Phase 2 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) in Subjects with Advanced Non-Sm … Recruiting
  2023-504595-26-00 4 2023-05-22 "Non-Small Cell Lung Cancer"
• A clinical study to investigate the efficacy and safety of an investigational combination therapy with BNT324 and BNT327 in patients with ad … Recruiting
  2024-520238-31-01 9 2026-04-20 "Advanced Lung Cancer"
• A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with … Recruiting
  2024-519344-32-00 9 2026-03-16 "Non-small Cell Lung Cancer"
• A Multicenter, Open-label, Randomized Phase 3 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) vs Investigator Choice of Single-ag … Recruiting
  2024-520164-33-00 5 2025-12-09 "Non-Small Cell Lung Cancer"
• IFCT-2401 SPORADIC a multicenter randomized open label phase II study evaluating the efficacy and the tolerance of adding cemiplimab to Sequ … Recruiting
  2024-517316-29-00 4 2025-11-07 "Unresectable stage III Non-Small Cell Lung Cancer"
• Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting
  2024-515764-31-00 10 2025-06-13 "Non-small cell lung cancer"
• A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun … Recruiting
  2023-506539-14-00 3 2025-05-27 "Oncology"
• A study to evaluate the benefit of adding durvalumab after chemotherapy, durvalumab and surgery in patients with early-stage, operable, non- … Recruiting
  2023-508773-82-00 5 2025-05-06 "Stage IIB-IIIB (N2) resectable non small cell lung cancer"
• PACCELIO - FDG-PET based small volume accelerated immuno chemoradio-therapy in locally advanced NSCLC Recruiting
  2023-510506-41-00 4 2024-04-15 "Locally advanced, unresectable non-small-cell lung cancer (N"
• Study of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE) Recruiting
  2023-507778-42-00 4 2023-03-08 "Non-Small Cell Lung Cancer II, III"
• Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting
  2023-508852-21-00 4 2022-06-10 "Resectable, Early-stage (II to IIIB) Non-small Cell Lung Can"
• Radiotherapy to enhance the effects of an immune therapy before tumor surgery in patients with advanced non-small cell lung cancer (NSCLC). … Recruitment ended
  2023-504536-18-00 4 2024-07-31 "Resectable, locally advanced non-small cell lung cancer (NSC"
• A trial to learn if taking osimertinib before and after chemotherapy and radiation therapy is safe and works in adults with non-small cell … Recruitment ended
  2023-507798-16-00 4 2024-04-16 "Unresectable Non-small Cell Lung Cancer"
• A research study to evaluate the activity of Sotorasib for the treatment of patients with non-operable non-small cell lung cancer with a KRA … Recruitment ended
  2024-511268-10-00 4 2022-05-25 "Unresectable stage III (IIIA-N2, IIIB, IIIC) KRAS p.G12C non"
• A global study to assess the effects of Osimertinib following chemoradiation in patients with Stage III unresectable non-small cell lung can … Recruitment ended
  2022-500860-36-00 5 2018-09-19 "Histologically documented non-small cell lung cancer of pred"
• A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered i … Ended
  2023-506696-10-00 5 2024-06-18 "Non-Small Cell Lung Cancer"
• A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE Ended
  2022-502716-37-00 4 2023-11-27 "Recurrent or advanced/metastatic solid tumors who are immuno"
• A Study of Atezolizumab in Patients with Locally Advanced, Unresectable Stage III Non−Small Cell Lung Cancer who have already received chemo … Ended
  2023-503756-27-00 4 2022-03-31 "Non-Small Cell Lung Cancer (NSCLC)"

Showing 1–24 of 28 trials